HOME > TOP STORIES
TOP STORIES
-
REGULATORY Pharmacist LDP Candidate Eager for National Debate on Drug Pricing
June 7, 2022
-
REGULATORY Public-Private Confab Set for June 14, Talks on Data Utilization Expected
June 7, 2022
-
REGULATORY Scrap All Barriers, Annual Drug Re-Pricing to Boost International Competitiveness of Japan Pharma: LDP’s Jimi
June 6, 2022
-
BUSINESS Gilead Japan Eyes High-Single-Digit Annual Growth with Oncology as Third Biz Pillar
June 3, 2022
-
COMMENTARY New Zero Premium Rule Applied to 6 Drugs Since April Rollout, Is It Incentivizing Cost Disclosure?
June 2, 2022
-
BUSINESS Shashank Deshpande to Take Reins at Nippon Boehringer Ingelheim
June 2, 2022
-
REGULATORY Honebuto Draft Makes No Mention of Off-Year Re-Pricing or Buffer Zone, Calls for Stronger Drug Discovery Capabilities
June 1, 2022
-
BUSINESS Takeda to Transfer Spikevax Authorization to Moderna in Japan, 3-Way Purchase Deal to End
June 1, 2022
-
ACADEMIA NCGM, IQVIA Pair Up to Unravel “Long COVID” by Building Large-Scale Registry
May 31, 2022
-
REGULATORY Janssen’s COVID-19 Vaccine in Line for Japan Approval, No Supply Deal Signed
May 31, 2022
-
BUSINESS Japan Drug Majors Expand Global Oncology Sales in FY2021
May 30, 2022
-
BUSINESS Moderna Eyes Bivalent Booster Rollout This Fall via Emergency Approval Path in Japan: CMO
May 30, 2022
-
BUSINESS AstraZeneca Tops Foreign Pharma Ranking in 2021, Pfizer Sales Undisclosed: Jiho
May 27, 2022
-
REGULATORY Japan Approves Additional Indications, Dosages for Rinvoq, Adcetris, Rozex, and More
May 27, 2022
-
BUSINESS Top 4 Wholesalers Log 62% Rise in Operating Profit in FY2021 on Rebound in Doctor Visits
May 27, 2022
-
BUSINESS Sandoz Japan on Hunt for Biosimilar In-Licensing, Sales Tie-Ups after Avastin Deal
May 26, 2022
-
BUSINESS Japan Pharma Market Up 3.3% in FY2021, Opdivo Rises to No.1: IQVIA
May 26, 2022
-
REGULATORY MOF Panel Nudges Full Annual Drug Re-Pricing, Phase-Out for 2% Buffer Zone
May 26, 2022
-
BUSINESS Vabysmo, Ondexxya, Ozempic 2 mg Pen Now Available in Japan
May 26, 2022
-
BUSINESS Novavax Vaccine Officially Added to Japan’s Free COVID-19 Inoculation Program
May 26, 2022
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
